Securities Registration (section 12(b)) (8-a12b)
13 Juin 2023 - 10:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF
THE SECURITIES EXCHANGE ACT OF 1934
CalciMedica,
Inc.
(Exact name of Registrant as specified in its charter)
|
|
|
Delaware |
|
45-2120079 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
505 Coast Boulevard South, Suite 307
La Jolla, California |
|
92037 |
(Address of principal executive offices) |
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class to be so registered |
|
Name of each exchange on which each class is to be
registered |
Common Stock, par value $0.0001 per share |
|
The Nasdaq Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c) or (e), check the following box. ☒
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐
If this
form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement or Regulation A offering statement file number to which this form relates:
333-248611 (if applicable)
Securities to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrants Securities to be Registered.
CalciMedica, Inc. (the Registrant) hereby incorporates by reference the description of its common stock, par value $0.0001 per share,
to be registered hereunder contained under the heading Description of Capital Stock in the Registrants Registration Statement on Form S-1 (File
No. 333-248611), as originally filed with the Securities and Exchange Commission (the Commission) on September 4, 2020, as subsequently amended (the Registration
Statement), and in the prospectus included in the Registration Statement to be filed separately by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, which prospectus shall be
deemed to be incorporated by reference herein.
Item 2. Exhibits.
In accordance with the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be
filed as part of this registration statement because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities
Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this registration statement
to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: June 13, 2023
|
|
|
CalciMedica, Inc. |
|
|
By: |
|
/s/ A. Rachel Leheny, Ph.D. |
|
|
A. Rachel Leheny, Ph.D. |
|
|
Chief Executive Officer |
Graybug Vision (NASDAQ:GRAY)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Graybug Vision (NASDAQ:GRAY)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024